2seventy bio Inc

+0.37 (+3.15%)
Earnings Announcements

2Seventy Bio Reports Q1 Results And Recent Operational Progress

Published: 05/12/2022 20:32 GMT
2seventy bio Inc (TSVT) - 2seventy Bio Reports First Quarter Financial Results and Recent Operational Progress.
Q1 Revenue $56 Million.
Ended Quarter With $452.5m Cash, Cash Equivalents, and Marketable Securities; Anticipated Cash Runway Into 2025.
Qtrly Net Loss per Share - Basic and Diluted $3.20.
Q1 Earnings per Share View $-2.05 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $21.7 Million
Adjusted EPS is expected to be -$1.98

Next Quarter Revenue Guidance is expected to be $22.7 Million
Next Quarter EPS Guidance is expected to be -$1.85

More details on our Analysts Page.